Rory B. Riggs, Director at Royalty Pharma plc (RPRX), bought 15,000 shares at $28.00 ($420K) on 2020-06-18, disclosed to the SEC on 2020-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |